TY - JOUR
T1 - Primary effusion lymphoma
AU - Patel, Sanjay
AU - Xiao, Philip
N1 - Funding Information:
Supported in part by a grant from the Ministry of Health , Rome, within the framework of the Progetto Integrato Oncologia–Advanced Molecular Diagnostics project grant RFPS-2006-2-342010.7 (A.C.) and by a grant from CRO Aviano National Cancer Institute for an intramural project “Infectious Agents and Tumors” (A.C.).
PY - 2013/8
Y1 - 2013/8
N2 - Primary effusion lymphoma is a large cell non-Hodgkin lymphoma localized predominantly in body cavities and occasionally in extracavitary regions. It presents with characteristic lymphomatous effusions in the absence of solid tumor masses, and pleural, peritoneal, and pericardial spaces are most often involved. It is typically associated with human herpesvirus 8 infection in immunocompromised individuals, in the setting of human immunodeficiency virus infection, organ transplantation, or in rare cases advanced age. Histologically, primary effusion lymphoma is characterized by atypical lymphoid cells of B-cell lineage with large nuclei and prominent nucleoli. Demonstration of human herpesvirus 8 latent antigens is required for diagnosis, and treatment modalities are limited at this time. In this review, we aim to summarize clinicopathologic features of this rare and unique entity.
AB - Primary effusion lymphoma is a large cell non-Hodgkin lymphoma localized predominantly in body cavities and occasionally in extracavitary regions. It presents with characteristic lymphomatous effusions in the absence of solid tumor masses, and pleural, peritoneal, and pericardial spaces are most often involved. It is typically associated with human herpesvirus 8 infection in immunocompromised individuals, in the setting of human immunodeficiency virus infection, organ transplantation, or in rare cases advanced age. Histologically, primary effusion lymphoma is characterized by atypical lymphoid cells of B-cell lineage with large nuclei and prominent nucleoli. Demonstration of human herpesvirus 8 latent antigens is required for diagnosis, and treatment modalities are limited at this time. In this review, we aim to summarize clinicopathologic features of this rare and unique entity.
UR - http://www.scopus.com/inward/record.url?scp=84881060269&partnerID=8YFLogxK
U2 - 10.5858/arpa.2012-0294-RS
DO - 10.5858/arpa.2012-0294-RS
M3 - Review article
C2 - 23899073
AN - SCOPUS:84881060269
SN - 0003-9985
VL - 137
SP - 1152
EP - 1154
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
IS - 8
ER -